AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

RecruitingNAAges 18 Years - anyFemaleFetalEase Ltd.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Subject 18 years of age or older at time of consent. 2. Subject planning on vaginal birth. 3. Singleton pregnancy in vertex presentation. 4. Full-term pregnancy having completed 37 weeks or more gestational weeks. 5. Able and willing to provide written informed consent prior to enrollment. 6. In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF). 7. Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery." Exclusion Criteria: 1. Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ยฑ suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.) 2. Cesarean section is planned for the patient. 3. Obstetric contraindications to vaginal birth. 4. Subject carrying fetus with known significant chromosomal or structural anomalies. 5. Clinically estimated fetal weight โ‰ฅ5kg in non-diabetic subjects. 6. Clinically estimated fetal weight โ‰ฅ4.5kg in subjects with diabetes. 7. Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy. 8. Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc. 9. Any maternal disease or disorder that precludes the subject from pushing effectively. 10. If the maternal cervix is not fully dilated. 11. If the fetal head is not completely out of the birth canal. 12. In the presence of a non-reducible nuchal cord.
๐Ÿ’Š

What it tests

  • Yaari Extractor
๐Ÿ“

Where

4 sites
University of Miami - Jackson Memorial
Miami, United States
Rosemark WomenCare Specialist
Idaho Falls, United States
Unified Women's Clinical Research
Winston-Salem, United States
Inova Fairfax Medical Campus
Falls Church, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy